NCT02741739View on ClinicalTrials.gov

Study of the Blood Concentrations of Two Formulations of REGN1033 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

April 30, 2016

Study Completion Date

May 31, 2016

Conditions
Healthy
Interventions
DRUG

REGN1033

Trial Locations (1)

Unknown

San Antonio

All Listed Sponsors
lead

Regeneron Pharmaceuticals

INDUSTRY

NCT02741739 - Study of the Blood Concentrations of Two Formulations of REGN1033 in Healthy Subjects | Biotech Hunter | Biotech Hunter